Regional TechCamp Workshop Countering Disinformation
Proposed programs should be completed within 18 months or less. In order to be eligible to receive an award, all organizations must have a unique entity identifier (Data Universal Numbering System/DUNS number from Dun & Bradstreet), as well as a valid registration on www.SAM.gov. Please see Section D.3 for information on how to obtain these registrations. Individuals are not required to have a unique entity identifier or be registered in SAM.gov.
Funding Agency: US Mission to Malaysia
Deadline: September 2, 2019
Amount: $100,000
For more information: Visit grants.gov and search funding opportunity #SMY-300-FY19-TECH
BJA FY 19 An Academic-based Training Initative to Improve Police Responses for People with Mental Illness and Intellectual and Developmental Disabilities
This initiative focuses on developing academic-based, transdisciplinary crisis intervention training to educate, train, and prepare law enforcement officers so that they are equipped to appropriately interact with people who have mental illness and intellectual and developmental disabilities in the course of completing their job responsibilities.
Funding Agency: Bureau of Justice Assistance
Deadline: October 4, 2019
Amount: $2,254,000
For more information: https://www.bja.gov/funding/AcademicLETA19.pdf
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) supports applications to develop and implement a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website. This FOA will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion FOA that encourages applications for a collaborating Data Coordinating Center (PAR-19-NNN). The objective of the CCC application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. Both a CCC application and a collaborating Data Coordinating Center (DCC) application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application.
Funding Agency: NIH
Deadline: September 8, 2019
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-329.html
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) supports applications for a collaborating Data Coordinating Center (DCC) investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the definition of an NIH clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website. This FOA will utilize a cooperative agreement mechanism of award and runs in parallel with a companion FOA (PAR-19-NNN) that encourages applications for a collaborating Clinical Coordinating Center (CCC). The DCC application must be specific for the clinical trial being proposed in the collaborating CCC. The objective of the DCC application is to present a comprehensive plan to provide overall project coordination, administration, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a collaborating CCC application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA.
Funding Agency: NIH
Deadline: September 8, 2019
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-330.html
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Clinical trials supported by this FOA include Phase II and above clinical trials. These trials may include ones that test different therapeutic, behavioral, and/or prevention strategies. Trials for which this FOA applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website. This FOA will utilize a bi-phasic, milestone-driven mechanism of award. It is anticipated that applications will present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes the conduct of the trial, as well as plans for project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The multiple PD/PI model is strongly encouraged but not required. Applicants are encouraged to include a PD/PI with expertise in biostatistics, clinical trial design, and coordination. Due to the complex nature of conducting a clinical trial, applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application. Staff will be able to assist applicants in meeting the objectives of this FOA.
Funding Agency: NIH
Deadline: September 8, 2019
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-328.html
Shared Beringian Heritage Program 2020 Funding Call
The National Park Service Shared Beringian Heritage Program (SBHP) recognizes and celebrates the unique natural resources and cultural heritage shared by Russia and the United States in the region known as Beringia. From the Kolyma River in Russia to Alaska’s border with the Yukon Territory in Canada, this region includes the people, the land, and the water that connected the continents of North America and Asia during the Pleistocene ice ages. The area provides unparalleled opportunities to study both earth and human history. The overall purpose of the SBHP is to advance local, national, international understanding and preservation of the region’s resources and to sustain the cultural vitality of its indigenous people. Specific programmatic goals are to:
- Improve conservation, sustainability, and knowledge of the region’s natural and cultural resources;
- Preserve subsistence opportunities and other historic traditions and practices;
- Interpret and communicate about the region’s unique and internationally significant resources and values;
- Provide opportunities for cultural connections and knowledge exchange. To meet its goals, the SBHP funds projects that connect people and activities in the Beringia region. Proposed projects may be research-focused, community-based, educational, cultural, or conservational. Every project must demonstrate how it fulfills the goals of the SBHP.
Funding Agency: National Park Service
Deadline: October 21, 2019
Amount: $425,000
For more information: Visit grants.gov and search funding opportunity # P19AS00018
NEA Research Grants in the Arts, FY2020
Grant applications previously submitted to the Research: Art Works category will now be submitted to the Research Grants in the Arts category. The Arts Endowment’s support of a project may start on May 1, 2020, or any time thereafter. Grants generally may cover a period of performance of up to two years, with an exception for projects that include primary data collection as part of the proposed activity. Projects that include primary data collection may request up to three years. Grant Program Description These grants support research that investigates the value and/or impact of the arts, either as individual components of the U.S. arts ecology or as they interact with each other and/or with other domains of American life. Research Grants in the Arts offers support for projects in two areas:
- Track One: Value and Impact. These are matching grants ranging from $10,000-$30,000 for research projects that aim to examine the value and/or impact of the arts in any topic area(s) by using data and methods appropriate to the proposed research questions.
- Track Two: Experimental and Quasi-Experimental Designs. These are matching grants ranging from $30,000-$100,000 for research projects that aim to test the causal or inferred-causal impact of the arts on individual or cohort outcomes by using experimental or quasi-experimental design methods appropriate to the proposed research questions.
Funding Agency: National Endowment for the Arts
Deadline: October 3, 2019
Amount: $100,000
For more information: https://www.arts.gov/grants-organizations/research-grants-in-the-arts
The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed)
This FOA invites applications on novel studies of the molecular mechanisms underlying metformins effects on aging and longevity. The goal of this FOA is to support applications that will lead to an in-depth understanding of the molecular mechanisms that determine the effects of metformin, either beneficial or detrimental, in relation to aging and longevity. Research supported by this FOA should lead to new insights and better understanding of metformins effects on aging and aging-related diseases.
Funding Agency: NIH
Deadline: January 21, 2020
Amount: $250,000
For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-044.html
Landscape Approaches to Resource Stewardship
This Modification looks outside of NCR park borders to understand the value, utility, and opportunities of NPS resources as they relate to a broader landscape context. Phase III will be developed in collaboration with NPS to synthesize data from parks with resource information mapped across the greater regional landscape to identify the best NPS-NCR opportunities for preserving the environmentally, culturally and historically significant resources within and across the National Capital Region parks.
Funding Agency: National Park Service
Deadline: August 17, 2019
Amount: $100,000
For more information: Visit grants.gov and search funding opportunity #P19AS00476
OSERS-OSEP: Technical Assistance and Dissemination Center for the Development and Implementation of High-Quality Instruction, Interventions, and Services for Children with Disabilities CFDA Number 84.326C
The mission of the Office of Special Education and Rehabilitative Services (OSERS) is to improve early childhood, educational, and employment outcomes and raise expectations for all people with disabilities, their families, their communities, and the Nation. As such, the Department of Education (Department) is issuing a notice inviting applications for new awards for fiscal year (FY) 2019 for a Technical Assistance and Dissemination Center for the Development and Implementation of High-Quality Instruction, Interventions, and Services for Children with Disabilities, Catalog of Federal Domestic Assistance (CFDA) number 84.326C. This Center will develop knowledge, curate resources, and disseminate information related to (1) enabling children with disabilities to make progress toward meeting challenging goals and objectives in light of each child’s circumstances, and (2) supporting local educational agencies (LEAs), charter management organizations (CMOs),private school associations, and schools in developing and implementing high-quality individualized educational programming. This notice relates to the approved information collection under OMB control number 1820-0028.
Funding Agency: Department of Education
Deadline: September 6, 2019
Amount: $2,000,000
For more information: Visit grants.gov and search funding opportunity #ED-Grants-080719-001
OSERS-OSEP: Technical Assistance and Dissemination to Improve Services and Results for Children with Disabilities – National Technical Assistance Center for Systemic Improvement Catalog of Federal Domestic Assistance (CFDA) number 84.326R
The mission of the Office of Special Education and Rehabilitative Services (OSERS) is to improve early childhood, educational, and employment outcomes and raise expectations for all people with disabilities, their families, their communities, and the Nation. As such, the Department of Education (Department) is issuing a notice inviting applications for new awards for fiscal year (FY) 2019 for a National Technical Assistance Center for Systemic Improvement, Catalog of Federal Domestic Assistance (CFDA) number 84.326R. This Center will provide differentiated support to States to help them best use their general supervision and professional development (PD) systems to establish and meet high expectations for each child with a disability. This notice relates to the approved information collection under OMB control number 1820-0028.
Funding Agency: Department of Education
Deadline: September 9, 2019
Amount: $6,250,000
For more information: Visit grants.gov and search funding opportunity #ED-Grants-080819-002
Basic Science Research Grants
The Harry J. Lloyd Charitable Trust provides a basic science grant to gain new biological insights in to melanoma development or progression. Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection. Applications will be accepted for a broad range of melanoma research projects involving basic science, clinical trials, etc. An adequate discussion of biostatistics is required, including but not limited to specification of numbers of cell lines, laboratory animals, or patients to be treated in the studies. Plans for adjustment for multiple looks should be presented, particularly in regards to clinical endpoints and evaluation of multiple biomarkers.
Funding Agency: Lloyd (Harry J.) Charitable Trust
Deadline: November 1, 2019
Amount: $125,000
For more information: https://hjltrust.com/apply/application-guidelines/
Career Development Grants
The Harry J. Lloyd Charitable Trust provides a grant to be used for salary support for promising young MD or PhD melanoma investigators. Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection. Applications will be accepted for a broad range of melanoma research projects involving basic science, clinical trials, etc. An adequate discussion of biostatistics is required, including but not limited to specification of numbers of cell lines, laboratory animals, or patients to be treated in the studies. Plans for adjustment for multiple looks should be presented, particularly in regards to clinical endpoints and evaluation of multiple biomarkers.
Funding Agency: Lloyd (Harry J.) Charitable Trust
Deadline: November 1, 2019
Amount: $125,000
For more information: https://hjltrust.com/apply/application-guidelines/
Translational Research Grants
The Harry J. Lloyd Charitable Trust provides a Translational Research grant to fund clinically important melanoma research. Applications will be accepted for a broad range of melanoma research projects involving basic science, clinical trials, etc. An adequate discussion of biostatistics is required, including but not limited to specification of numbers of cell lines, laboratory animals, or patients to be treated in the studies. Plans for adjustment for multiple looks should be presented, particularly in regards to clinical endpoints and evaluation of multiple biomarkers.
Funding Agency: Lloyd (Harry J.) Charitable Trust
Deadline: November 1, 2019
Amount: $125,000
For more information: https://hjltrust.com/apply/application-guidelines/